Sanjay Juneja, M.D.’s Post

Over the past 30 years, the Tri-Con has covered all aspects of cancer drug and diagnostic development. In the year of Artificial Intelligence, we are excited to offer a full day of sessions and panels addressing the impact of AI on Precision Oncology. Thank you to Douglas Flora, MD, LSSBB, FACCC for helping us organize. We look forward to hearing from thought leaders in the field, including Ezra Cohen, Scott Penberthy, Sanjay Juneja, M.D., Eric Stahlberg, Oscar Puig, Ben Glass, Arturo LoAIza-Bonilla MD, and Sean Khozin.   Please join Cambridge Healthtech Institute’s 31st International Precision Med TRI-CON, March 26-28, 2024 in San Diego. Visit www.triconference.com for detailed program and to register. Our last registration deadline is extended to tomorrow, plus you can use my code “LI200” for additional $200 discount. Look forward to seeing you in sunny San Diego! #precisionmedicine #ai #artificialintelligence #aiinhealthcare #aiinmedicine #aiinnovation #liquidbiopsy #genomics #personalizedmedicine #diagnostics #moleculardiagnostics #precisionhealth #digitalhealth #digitalmedicine #pointofcare #precisiononcology #ngs #circulatingtumorcells #cancerresearch #biomarkers #companiondiagnostics #immunooncology #spatialbiology #singlecell #raredisease #newbornsequencing #mced #earlydetection #genomicmedicine #innovation #cancerdiagnostics

PathAI’s Ben Glass, VP of Product & Translational Research, will share his expertise later this month at the 31st International Precision Med TRI-CON. His featured panel session, Artificial Intelligence in Precision Oncology, will bring together thought leaders and experts from across the field to discuss emerging opportunities for investment, innovation and commercialization of AI-enabled technologies and solutions for precision oncology. #precisionmedicine #digitalpathology #precisiononcology #artificialintelligence

This week, during European Lung Cancer Week, we want to highlight the power of scientific visualization to raise awareness of the disease and its symptoms. Lung cancer remains one of the leading causes of death worldwide, claiming countless lives each year. Early diagnosis can make a big difference in outcomes. At 3DforScience, we know that understanding begins with clear communication. Using advanced 3D animation and scientific illustration tools, we help pharmaceutical and biotech companies effectively communicate the complex aspects of modern medicine. Our services range from 3D animations that illustrate cellular processes and drug mechanisms of action to augmented reality models that allow healthcare professionals to explore organs and pathologies in detail. With these tools, we don't just present information; we make it accessible and easy to understand. In a world where innovation is crucial, scientific visualization is a strategic differentiator for companies looking to lead in healthcare research, development and education. Want to see how we can help your company stand out with impactful visual storytelling? Learn more about us on our website: https://lnkd.in/eNHDsTvf #3DforScience #MedicalInnovation #Innovation #ScienceCommunication #MedicalIllustration #LungCancerAwareness #EuropeanLungCancerWeek #HealthcareCommunication

We're thrilled to announce our participation in this pivotal event in the #oncology world. As a leading AI-based drug discovery company, we are revolutionizing #cancer treatment through advanced #data solutions. Meet our Chief Medical Officer, Prof. Juergen Scheele, MD, PhD, to explore how our cutting-edge technologies can support your clinical development programs. Our Offerings Include: Synthetic Control Arms: Optimize single-arm trials, especially for small biomarker-defined indications.  Comparative Effectiveness Research: Gain insights into drugs with similar mechanisms of action and understand unique indications better.  AI-Driven Data Solutions: Leverage our extensive datasets for machine learning, including molecular, pathology and radiology imaging.  Virtual Patients: Enhancing clinical trials and market authorization with our comprehensive virtual patient models specifically for lung cancer.  We are committed to partnering with global oncology leaders to create impact and support innovative #drug development. If you want to transform your cancer trials, we’re eager to connect at ESMO - European Society for Medical Oncology 2024 or set up a virtual meeting to discuss how we can collaborate.  Prof. Juergen Scheele #LungCancer #ESMO2024 #AIinHealthcare #OncologyInnovation #ClinicalDevelopment

🚀 Excited to Share My Latest Project: Lung Cancer Prediction Using Machine Learning Classification 🚀 🌟 Project Description: I'm thrilled to present my latest project where I've developed a machine learning model to predict the likelihood of an individual having lung cancer. This model leverages various health indicators and demographic information to assist healthcare professionals in the early detection and diagnosis of lung cancer. 🎯 Objective: The primary objective of this project is to create a robust predictive model that can identify the likelihood of lung cancer in individuals. By doing so, the aim is to enable timely interventions and improve patient outcomes, ultimately contributing to better healthcare delivery. This project has been a significant step towards utilizing data science and machine learning for impactful healthcare solutions. The potential to aid in early detection and provide critical insights for healthcare professionals is incredibly motivating. The Project : https://lnkd.in/dHGfcq9d #MachineLearning #DataScience #HealthcareInnovation #LungCancerPrediction #AIinHealthcare #EarlyDetection #HealthTech #CancerResearch #machinelearning #dataanalysis

#Researchers from MIT recently created an #Almodel that can #detect #breastcancer 5 years before it develops. Al is going to save so many lives. Here's how it works: → The model analyzed chromatin images from 560 tissue samples (122 patients), identifying 8 distinct cell states across ductal carcinoma in situ (DCIS) stages. → It considers both cellular composition and spatial arrangement, revealing that tissue organization is crucial in predicting disease progression. → The Al uses a convolutional variational autoencoder to learn from simple chromatin staining images, which is cheaper and easier than complex sequencing. → Surprisingly, cell states associated with invasive cancer were detected even in seemingly normal tissue. With current 5-year survival rates for breast cancer at ~90% when detected early, imagine the lives that could be saved with a 5-year head start on treatment. And as groundbreaking as this is, it's only scratching the surface. The impact Al will have on #healthcare within the next decade is likely far greater than most realize. +when detected early, imagine the lives that could be saved with a 5-year head start on treatment. And as groundbreaking as this is, it's only scratching the surface. The impact Al will have on healthcare within the next decade is likely far greater than most realize. #mit #mit #technology #news

Please mark your calendars now for October 30th for the first annual Google Cloud Health Cancer AI Summit in Boston MA. This exclusive one-day event will bring together healthcare and technology experts from the public sector, biotech, life sciences, pharmaceuticals, and leading cancer associations. We are creating a unique, unprecedented opportunity to present top-tier content and share where we are today – and where we can quickly move ahead collaboratively to unlock breakthroughs in personalized medicine, drug discovery, and AI-driven cancer care. More details to follow! TY Joe Timmons #HackCancer #HackCancerSF #LetsBeatCancer #AI #GCPCloud #HCLS #Google

The landscape of #medicine has always been characterized by its dynamic evolution, adapting and advancing through the ages albeit at a slow pace. Among the most transformative developments of recent decades are #precisionmedicine, #artificialintelligence (#AI), and sophisticated #cancerscreening techniques. In this special issue of AI in Precision Oncology , we focus on #cancer #screening and #earlydetection. We have complied #research from prominent clinicians, scientists and engineers to showcase where the field is now and where it is heading. The pace of advancement is such that it require a journal such is dedicated exclusively for this field. The fusion of precision medicine, artificial intelligence, and advanced cancer screening techniques heralds a transformative era in cancer care. As these fields continue to evolve and converge, they hold the promise of a future where cancer detection and prevention are personalized, precise, and profoundly effective, benefiting individuals and society as a whole and creating a potential where cancer can become a preventable and mostly curable disease. #healtcareonlinkedin #innovation Douglas Flora, MD, LSSBB, FACCC Nikhil Thaker, MD Mary Ann Liebert, Inc.

Well, that's a wrap for #AACR2024! As always, the conference was a milestone event, the first big oncology event of the year, showcasing a remarkable convergence of professionals across all levels of their careers, with a strong emphasis on supporting early career scientists. This year, the conference stood out to me for integrating more AI and spatial biology content than ever, reflecting cutting-edge trends in cancer research. With over 20,000 participants and 7,000+ posters, it highlighted the vast scope of work from basic science to high-impact clinical trials, including the growing importance of data science in understanding and treating cancer. 🎩 Hat tip to the organizers for putting together a fantastic program that is as much to nurture early career scientists as it is to foster collaboration amongst large industry partners. 💡 I'd love to see more of a patient perspective at the next one. There is nothing more motivating than hearing from the people we are attempting to treat. Without it, we may be striving for endpoints that are not of the most value to patients. Many clinicians have the opportunity to hear this perspective daily, but the overwhelming majority of the attendees at this conference do not have that privilege. ❤️ Thanks to those of you who made the conference special for me - not just the folks I have a decades-long working relationship with but also to the new connections I made - I'm looking forward to doing innovative cancer research with you in the coming years! #CancerResearch #AI #SpatialBiology #AACR24

There’s a new era in cancer care, one that is advancing healthcare with an approach unique as you. As GE HealthCare continues its countdown to World Theranostics Day on March 31st, we would like to highlight some of today’s pioneers driving innovation with their shared vision for better patient outcomes and more personalized cancer care. Recently, the #University Hospital Essen, Germany, led by department head Prof. @Ken Herrmann, is making a significant investment to build a brand new Theranostics Center of Excellence, covering remarkable innovations from tracer development and production to imaging and advanced AI capabilities, helping to position themselves as a global leader in precision care and oncology. Stories like these showcase the initiatives unlocking the potential of Theranostics through advancing research and development, shaping the future of Molecular Imaging. Discover how GE HealthCare is transforming the approach to cancer discovery, diagnosis, and treatment monitoring: https://lnkd.in/eEqqchmE #TheranosticsDay #HealthcareInnovation #PersonalizedMedicine #Theranostics #HealthTech #MolecularImaging #UniversityHospitalEssen #GEHealthCare